Omnicell, Inc. (OMCL)Healthcare | Health Information Services | Fort Worth, United States | NasdaqGS
33.08 USD
-0.33
(-0.988%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 33.08 |
Hot Take ↕ | Aug. 22, 2026, 2:06 a.m. EDT
The investment case for Omnicell is currently broken by a severe disconnect between its historical performance and its recent reality. While the company boasts a pristine balance sheet with manageable debt and a forward P/E that looks attractive on paper, the market has punished the stock relentlessly, dragging it down four consecutive years. This multi-year decline is the defining feature of the chart, signaling that investors see structural deterioration in the business despite the recent revenue beat. The lack of any dividend payout removes a key income floor, leaving shareholders exposed entirely to capital appreciation in a sector that appears to be losing favor. Options activity confirms this pessimism, with heavy put buying suggesting a fear of further downside. Until the stock can demonstrate a sustained reversal in its price trajectory or a clear inflection in growth that justifies the current valuation, it remains a speculative hold rather than a core investment. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.082572 |
| AutoETS | 0.082889 |
| AutoTheta | 0.082910 |
| MSTL | 0.082996 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 1.80 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.282 |
| Excess Kurtosis | -1.06 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 15.484 |
| Revenue per Share | 27.489 |
| Market Cap | 1,508,940,416 |
| Trailing P/E | 39.86 |
| Forward P/E | 15.83 |
| Beta | 0.97 |
| Profit Margins | 3.14% |
| Website | https://www.omnicell.com |
As of Aug. 22, 2026, 2:06 a.m. EDT: Speculators are overwhelmingly positioning for downside protection rather than upside participation. Put open interest significantly exceeds call open interest across all expirations, with deep out-of-the-money puts showing massive accumulation relative to volume. While there is some call activity at strikes above the current price, the sheer density of put writing suggests a market consensus expecting further weakness or volatility, with traders hedging against a drop to $25-$30.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.030529618 |
| Address1 | 4,220 North Freeway |
| All Time High | 187.29 |
| All Time Low | 1.29 |
| Ask | 42.43 |
| Ask Size | 2 |
| Audit Risk | 2 |
| Average Analyst Rating | 1.4 - Strong Buy |
| Average Daily Volume10 Day | 664,330 |
| Average Daily Volume3 Month | 750,992 |
| Average Volume | 750,992 |
| Average Volume10Days | 664,330 |
| Beta | 0.973 |
| Bid | 33.19 |
| Bid Size | 1 |
| Board Risk | 5 |
| Book Value | 28.317 |
| City | Fort Worth |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 2 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 33.08 |
| Current Ratio | 1.644 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 33.76 |
| Day Low | 32.865 |
| Debt To Equity | 15.484 |
| Display Name | Omnicell |
| Earnings Call Timestamp End | 1,785,414,600 |
| Earnings Call Timestamp Start | 1,785,414,600 |
| Earnings Growth | 3.333 |
| Earnings Quarterly Growth | 3.307 |
| Earnings Timestamp | 1,785,414,600 |
| Earnings Timestamp End | 1,793,277,000 |
| Earnings Timestamp Start | 1,793,277,000 |
| Ebitda | 82,184,000 |
| Ebitda Margins | 0.06592 |
| Enterprise To Ebitda | 17.239 |
| Enterprise To Revenue | 1.136 |
| Enterprise Value | 1,416,771,328 |
| Eps Current Year | 2.26875 |
| Eps Forward | 2.09 |
| Eps Trailing Twelve Months | 0.83 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 39.7186 |
| Fifty Day Average Change | -6.6385994 |
| Fifty Day Average Change Percent | -0.16714081 |
| Fifty Two Week Change Percent | 3.0529618 |
| Fifty Two Week High | 55.0 |
| Fifty Two Week High Change | -21.919998 |
| Fifty Two Week High Change Percent | -0.3985454 |
| Fifty Two Week Low | 29.06 |
| Fifty Two Week Low Change | 4.0200024 |
| Fifty Two Week Low Change Percent | 0.13833456 |
| Fifty Two Week Range | 29.06 - 55.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 997,363,800,000 |
| Float Shares | 44,378,721 |
| Forward Eps | 2.09 |
| Forward P E | 15.827753 |
| Free Cashflow | 134,181,872 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 3,485 |
| Fullday Change | -0.329998 |
| Fullday Change Percent | -0.987722 |
| Fullday Price | 33.08 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.44014 |
| Gross Profits | 548,726,976 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.021459999 |
| Held Percent Institutions | 1.08279 |
| Implied Shares Outstanding | 45,614,884 |
| Industry | Health Information Services |
| Industry Disp | Health Information Services |
| Industry Key | health-information-services |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas. |
| Long Name | Omnicell, Inc. |
| Market | us_market |
| Market Cap | 1,508,940,416 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_32401 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 39,083,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,523,993,274 |
| Number Of Analyst Opinions | 7 |
| Open | 33.52 |
| Operating Cashflow | 181,435,008 |
| Operating Margins | 0.05909 |
| Overall Risk | 5 |
| Payout Ratio | 0.0 |
| Peg Ratio | 15.4 |
| Phone | 877 415 9990 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 33.08 |
| Post Market Time | 1,787,959,805 |
| Previous Close | 33.41 |
| Price Eps Current Year | 14.580717 |
| Price Hint | 2 |
| Price To Book | 1.1682029 |
| Price To Sales Trailing12 Months | 1.2103448 |
| Profit Margins | 0.03135 |
| Quick Ratio | 1.194 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.375 |
| Region | US |
| Regular Market Change | -0.329998 |
| Regular Market Change Percent | -0.987722 |
| Regular Market Day High | 33.76 |
| Regular Market Day Low | 32.865 |
| Regular Market Day Range | 32.865 - 33.76 |
| Regular Market Open | 33.52 |
| Regular Market Previous Close | 33.41 |
| Regular Market Price | 33.08 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 538,712 |
| Return On Assets | 0.0152199995 |
| Return On Equity | 0.03059 |
| Revenue Growth | 0.075 |
| Revenue Per Share | 27.489 |
| Sand P52 Week Change | 0.20204377 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 45,614,884 |
| Shares Percent Shares Out | 0.0738 |
| Shares Short | 3,368,461 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 3,587,279 |
| Short Name | Omnicell, Inc. |
| Short Percent Of Float | 0.0896 |
| Short Ratio | 4.16 |
| Source Interval | 15 |
| State | TX |
| Symbol | OMCL |
| Target High Price | 70.0 |
| Target Low Price | 45.0 |
| Target Mean Price | 57.85714 |
| Target Median Price | 60.0 |
| Total Cash | 292,164,992 |
| Total Cash Per Share | 6.405 |
| Total Debt | 199,996,000 |
| Total Revenue | 1,246,702,976 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.83 |
| Trailing P E | 39.855423 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 40.73385 |
| Two Hundred Day Average Change | -7.6538467 |
| Two Hundred Day Average Change Percent | -0.18789893 |
| Type Disp | Equity |
| Volume | 538,712 |
| Website | https://www.omnicell.com |
| Zip | 76,137 |